首页> 外国专利> Use of highly effective therapeutic clonal derivatives to produce a pharmaceutical ingredient for the treatment of urinary incontinence a

Use of highly effective therapeutic clonal derivatives to produce a pharmaceutical ingredient for the treatment of urinary incontinence a

机译:使用高效的治疗性克隆衍生物生产用于治疗尿失禁的药物成分

摘要

It involves how to deal with urinary incontinence related to the high incidence of schizophrenia and how to reduce the need or frequency of cleaning intermittent catheters by injecting a cloned derivative into the bladder.One patient 1. Use highly effective therapeutic clonal derivatives to culture drug ingredients for the treatment of urinary incontinence caused by over stimulation of nerve derivatives in patients requiring treatmentIts composition does not exceed 200 chloropropene derivatives. Clostrial derivative is a botulinum toxin, which is best selected from botulinum toxin A, B, C, D, e, F and G.
机译:它涉及如何处理与精神分裂症高发有关的尿失禁,以及如何通过将克隆的衍生物注射到膀胱中来减少清洁间歇性导管的需要或频率。一名患者1.使用高效的治疗性克隆衍生物培养药物成分用于治疗需要治疗的患者过度刺激神经衍生物引起的尿失禁的成分不超过200个氯丙烯衍生物。梭菌衍生物是肉毒杆菌毒素,最好从肉毒杆菌毒素A,B,C,D,e,F和G中选择。

著录项

  • 公开/公告号AR106739A1

    专利类型

  • 公开/公告日2018-02-14

    原文格式PDF

  • 申请/专利权人 ALLERGAN INC.;

    申请/专利号AR2016P103526

  • 申请日2016-11-18

  • 分类号A61K38/48;A61P13/10;

  • 国家 AR

  • 入库时间 2022-08-21 12:54:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号